NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/08/2024
Back to search
Official data from USPTO
HYGEN PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HYGEN PHARMACEUTICALS
ST13
US500000074533934Class
42
Filing
74533934
Registration
1894478
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/08/2024
Trademark type
Word
Nice classes
42
Filing date
06/06/1994
Registration date
05/16/1995
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2024
Last transaction
08/08/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/01/1994
First use in commerce
01/01/1994
Drawing code
1
Owner type
03
Owner location
Redmond, WA
Examiner
MILTON, PRISCILLA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HYGEN PHARMACEUTICALS, INC.
HYGEN PHARMACEUTICALS, INC.
Representatives
Claire F. Hawkins Foster Garvey PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
wholesale distributorships featuring pharmaceuticals
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
08/08/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/08/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
05/20/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/16/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/07/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/07/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/22/2015
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/22/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/22/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/22/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
05/06/2015
CFIT
CASE FILE IN TICRS
06/28/2007
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/20/2005
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/20/2005
PLGL
ASSIGNED TO PARALEGAL
08/16/2005
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
05/04/2005
E89R
TEAS SECTION 8 & 9 RECEIVED
05/04/2005
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/21/2001
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
11/16/2001
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/1995
PUBO
PUBLISHED FOR OPPOSITION
02/21/1995
NPUB
NOTICE OF PUBLICATION
01/23/1995
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/22/1994
CNEA
EXAMINER'S AMENDMENT MAILED
10/27/1994
Continuous trademark protection
Get notified about every new filing that threatens HYGEN PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.